Danaher PE Ratio 2010-2025 | DHR

Current and historical p/e ratio for Danaher (DHR) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Danaher PE ratio as of July 14, 2025 is 26.54.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Danaher PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-15 192.86 37.45
2025-03-31 204.67 $5.15 39.74
2024-12-31 228.84 $5.28 43.34
2024-09-30 276.83 $5.24 52.83
2024-06-30 248.54 $5.63 44.15
2024-03-31 248.14 $5.90 42.06
2023-12-31 229.63 $6.39 35.94
2023-09-30 217.83 $7.93 27.47
2023-06-30 210.72 $8.52 24.73
2023-03-31 221.03 $9.28 23.82
2022-12-31 232.51 $9.65 24.09
2022-09-30 226.05 $9.05 24.98
2022-06-30 221.67 $8.49 26.11
2022-03-31 256.21 $8.64 29.65
2021-12-31 287.13 $8.62 33.31
2021-09-30 265.51 $7.89 33.65
2021-06-30 233.88 $7.51 31.14
2021-03-31 196.01 $6.35 30.87
2020-12-31 193.26 $4.87 39.68
2020-09-30 187.19 $4.94 37.89
2020-06-30 153.58 $4.67 32.89
2020-03-31 120.09 $4.40 27.29
2019-12-31 132.98 $4.05 32.83
2019-09-30 125.00 $3.37 37.09
2019-06-30 123.55 $3.41 36.23
2019-03-31 113.99 $3.39 33.62
2018-12-31 88.92 $3.73 23.84
2018-09-30 93.54 $3.89 24.05
2018-06-30 84.83 $3.77 22.50
2018-03-31 84.03 $3.61 23.28
2017-12-31 79.53 $3.53 22.53
2017-09-30 73.39 $3.39 21.65
2017-06-30 72.08 $3.14 22.96
2017-03-31 72.93 $3.29 22.17
2016-12-31 66.27 $3.66 18.11
2016-09-30 66.63 $3.58 18.61
2016-06-30 41.77 $5.03 8.30
2016-03-31 39.17 $5.06 7.74
2015-12-31 38.19 $4.76 8.02
2015-09-30 34.99 $4.69 7.46
2015-06-30 35.00 $3.63 9.64
2015-03-31 34.67 $3.61 9.60
2014-12-31 34.94 $3.63 9.63
2014-09-30 30.94 $3.82 8.10
2014-06-30 32.02 $3.71 8.63
2014-03-31 30.46 $3.63 8.39
2013-12-31 31.32 $3.80 8.24
2013-09-30 28.11 $3.58 7.85
2013-06-30 25.66 $3.51 7.31
2013-03-31 25.18 $3.48 7.24
2012-12-31 22.64 $3.36 6.74
2012-09-30 22.33 $3.27 6.83
2012-06-30 21.07 $3.24 6.50
2012-03-31 22.65 $3.34 6.78
2011-12-31 19.02 $3.11 6.11
2011-09-30 16.95 $3.00 5.65
2011-06-30 21.40 $3.21 6.67
2011-03-31 20.95 $2.82 7.43
2010-12-31 19.03 $2.64 7.22
2010-09-30 16.38 $2.35 6.99
2010-06-30 14.97 $1.92 7.79
2010-03-31 16.10 $1.82 8.87
2009-12-31 15.14 $1.73 8.75
Sector Industry Market Cap Revenue
Medical Medical Services $141.524B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $81.417B 10.12
Elevance Health (ELV) United States $76.834B 9.91
Cencora (COR) United States $57.577B 20.03
DiDi Global (DIDIY) China $25.180B 26.75
Natera (NTRA) United States $21.599B 0.00
Labcorp Holdings (LH) United States $20.908B 16.96
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.318B 0.00
CochLear (CHEOY) Australia $13.009B 0.00
Solventum (SOLV) United States $12.815B 13.57
ICON (ICLR) Ireland $12.075B 11.23
Revvity (RVTY) United States $11.607B 19.97
Viatris (VTRS) United States $10.727B 3.69
Medpace Holdings (MEDP) United States $9.208B 24.45
Avantor (AVTR) United States $9.009B 13.09
Sonic Healthcare (SKHHY) Australia $8.842B 0.00
HealthEquity (HQY) United States $8.418B 36.87
Charles River Laboratories (CRL) United States $7.762B 15.21
Caris Life Sciences,�Inc (CAI) United States $7.052B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.840B 28.50
BrightSpring Health Services (BTSG) United States $3.571B 32.76
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.880B 37.45
Alignment Healthcare (ALHC) United States $2.651B 0.00
Concentras Parent (CON) United States $2.593B 14.98
Organon (OGN) United States $2.550B 2.71
GeneDx Holdings (WGS) United States $2.351B 90.54
Ardent Health (ARDT) United States $2.073B 8.84
Progyny (PGNY) United States $2.012B 44.28
PACS (PACS) United States $1.966B 0.00
Premier (PINC) United States $1.750B 13.28
GoodRx Holdings (GDRX) United States $1.725B 34.50
Teladoc Health (TDOC) United States $1.451B 0.00
Establishment Labs Holdings (ESTA) $1.316B 0.00
Pediatrix Medical (MD) United States $1.131B 8.60
CareDx (CDNA) United States $1.115B 17.41
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.931B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.791B 7.41
Nutex Health (NUTX) United States $0.645B 9.76
Embecta (EMBC) United States $0.606B 4.08
InnovAge Holding (INNV) United States $0.582B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
LifeMD (LFMD) United States $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.487B 0.00
Auna S.A (AUNA) Luxembourg $0.473B 10.65
Omada Health (OMDA) $0.452B 0.00
So-Young (SY) China $0.430B 0.00
Enhabit (EHAB) United States $0.359B 29.50
COMPASS Pathways (CMPS) United Kingdom $0.347B 0.00
Performant Healthcare (PHLT) United States $0.331B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Beauty Health (SKIN) United States $0.236B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.142B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
Ascend Wellness Holdings (AAWH) United States $0.078B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Basel Medical Group (BMGL) Singapore $0.056B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
OSR Holdings (OSRH) United States $0.022B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00